20-HETE is associated with unfavorable outcomes in subarachnoid hemorrhage patients

Emerging evidence has suggested that patients experiencing aneurysmal subarachnoid hemorrhage (aSAH) develop vascular dysregulation as a potential contributor to poor outcomes. Preclinical studies have implicated the novel microvascular constrictor, 20-hydroxyeicosatetraenoic acid (20-HETE) in aSAH...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Cereb Blood Flow Metab
Egile Nagusiak: Donnelly, Mark K, Crago, Elizabeth A, Conley, Yvette P, Balzer, Jeffery R, Ren, Dianxu, Ducruet, Andrew F, Kochanek, Patrick M, Sherwood, Paula R, Poloyac, Samuel M
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2015
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4640341/
https://ncbi.nlm.nih.gov/pubmed/25920956
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/jcbfm.2015.75
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak